The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
October 3rd 2024
A study reveals that individuals with schizophrenia spectrum disorders experience high rates of comorbid mental health conditions and receive minimally adequate treatment.
September 26th 2024
September 20th 2024
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Paliperidone Palmitate Delays Relapse in Patients with Schizoaffective Disorder
May 7th 2014Patients with schizoaffective disorder who were treated with paliperidone palmitate (as monotherapy and adjunctive therapy) experienced delayed time to relapse and reduced risk of relapse compared to patients treated with placebo.
ADHD Drug Also Produces Promising Results in Adults with Binge Eating Disorder
May 7th 2014Adult patients with binge eating disorder who were treated for 12 weeks with lisdexamfetamine dimesylate reported having 4 fewer binge days per week, and also experienced improvements in weight and triglyceride levels.
Bremelanotide Treatment Improves Sexual Function and Reduces Associated Distress Levels in Women
May 7th 2014Patients in a trial of a first-in-class medication for the treatment of female sexual dysfunction reported improvement in overall sexual function, including an increase in the number of satisfying sexual events, and a concomitant decrease in distress levels associated with sexual dysfunction.
Vortioxetine May Also Improve Cognition in Adult Patients with Major Depressive Disorder
May 6th 2014Study results presented at the 2014 APA annual meeting show patients treated with vortioxetine significant improvement in composite cognition scores compared to patients treated with placebo, independent of the drug's effect on their depression symptoms.
Growing Awareness for Ketamine Treatment in Depression and Anxiety
May 6th 2014When I first considered intravenous ketamine to treat severely treatment-resistant depression 4 years ago, I was in a scary, lonely place where I received a lot of skeptical questions and funny looks accompanying chirping crickets.
Desvenlafaxine Safe and Effective for Major Depressive Disorder in 'Real-world' Trial Setting
May 5th 2014Small, "naturalistic" study shows treatment with desvenlafaxine produces high rates of symptom improvement and remission with low rates of adverse events in patients with major depressive disorder.
Despite rampant opioid misuse, abuse, and diversion self-reported by chronic pain patients in a study presented at the American Pain Society 33rd Annual Scientific Meeting, primary care providers tended to downgrade the patients' risk for engaging in those drug-related aberrant behaviors, indicating a gap between physicians' objective risk assessment for opioid abuse and the actual extent of the problem.
Restoring the Path to Multidisciplinary Chronic Pain Management
Although the concept of delivering chronic pain care through multidisciplinary clinics is less than half a century old, John Loeser, MD, believes the model has already surpassed its peak in the United States, mainly due to financial reasons.